img

Global DNA & RNA Oligonucleotides Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global DNA & RNA Oligonucleotides Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal DNA & RNA Oligonucleotides Market
The global DNA & RNA Oligonucleotides market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of DNA & RNA Oligonucleotides include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for DNA & RNA Oligonucleotides market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of DNA & RNA Oligonucleotides, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for DNA & RNA Oligonucleotides, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the DNA & RNA Oligonucleotides revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global DNA & RNA Oligonucleotides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for DNA & RNA Oligonucleotides revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc.



By Company


Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
Segment by Type
DNA Oligonucleotides
RNA Oligonucleotides

Segment by Application


Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of DNA & RNA Oligonucleotides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of DNA & RNA Oligonucleotides companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA & RNA Oligonucleotides revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 DNA Oligonucleotides
1.2.3 RNA Oligonucleotides
1.3 Market by Application
1.3.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA & RNA Oligonucleotides Market Perspective (2018-2034)
2.2 Global DNA & RNA Oligonucleotides Growth Trends by Region
2.2.1 DNA & RNA Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 DNA & RNA Oligonucleotides Historic Market Size by Region (2018-2024)
2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Region (2024-2034)
2.3 DNA & RNA Oligonucleotides Market Dynamics
2.3.1 DNA & RNA Oligonucleotides Industry Trends
2.3.2 DNA & RNA Oligonucleotides Market Drivers
2.3.3 DNA & RNA Oligonucleotides Market Challenges
2.3.4 DNA & RNA Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue DNA & RNA Oligonucleotides by Players
3.1.1 Global DNA & RNA Oligonucleotides Revenue by Players (2018-2024)
3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2018-2024)
3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of DNA & RNA Oligonucleotides, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2022
3.5 Global Key Players of DNA & RNA Oligonucleotides Head office and Area Served
3.6 Global Key Players of DNA & RNA Oligonucleotides, Product and Application
3.7 Global Key Players of DNA & RNA Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA & RNA Oligonucleotides Breakdown Data by Type
4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2018-2024)
4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2024-2034)
5 DNA & RNA Oligonucleotides Breakdown Data by Application
5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2018-2024)
5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America DNA & RNA Oligonucleotides Market Size (2018-2034)
6.2 North America DNA & RNA Oligonucleotides Market Size by Type
6.2.1 North America DNA & RNA Oligonucleotides Market Size by Type (2018-2024)
6.2.2 North America DNA & RNA Oligonucleotides Market Size by Type (2024-2034)
6.2.3 North America DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
6.3 North America DNA & RNA Oligonucleotides Market Size by Application
6.3.1 North America DNA & RNA Oligonucleotides Market Size by Application (2018-2024)
6.3.2 North America DNA & RNA Oligonucleotides Market Size by Application (2024-2034)
6.3.3 North America DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
6.4 North America DNA & RNA Oligonucleotides Market Size by Country
6.4.1 North America DNA & RNA Oligonucleotides Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America DNA & RNA Oligonucleotides Market Size by Country (2018-2024)
6.4.3 North America DNA & RNA Oligonucleotides Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe DNA & RNA Oligonucleotides Market Size (2018-2034)
7.2 Europe DNA & RNA Oligonucleotides Market Size by Type
7.2.1 Europe DNA & RNA Oligonucleotides Market Size by Type (2018-2024)
7.2.2 Europe DNA & RNA Oligonucleotides Market Size by Type (2024-2034)
7.2.3 Europe DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
7.3 Europe DNA & RNA Oligonucleotides Market Size by Application
7.3.1 Europe DNA & RNA Oligonucleotides Market Size by Application (2018-2024)
7.3.2 Europe DNA & RNA Oligonucleotides Market Size by Application (2024-2034)
7.3.3 Europe DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
7.4 Europe DNA & RNA Oligonucleotides Market Size by Country
7.4.1 Europe DNA & RNA Oligonucleotides Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2018-2024)
7.4.3 Europe DNA & RNA Oligonucleotides Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China DNA & RNA Oligonucleotides Market Size (2018-2034)
8.2 China DNA & RNA Oligonucleotides Market Size by Type
8.2.1 China DNA & RNA Oligonucleotides Market Size by Type (2018-2024)
8.2.2 China DNA & RNA Oligonucleotides Market Size by Type (2024-2034)
8.2.3 China DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
8.3 China DNA & RNA Oligonucleotides Market Size by Application
8.3.1 China DNA & RNA Oligonucleotides Market Size by Application (2018-2024)
8.3.2 China DNA & RNA Oligonucleotides Market Size by Application (2024-2034)
8.3.3 China DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia DNA & RNA Oligonucleotides Market Size (2018-2034)
9.2 Asia DNA & RNA Oligonucleotides Market Size by Type
9.2.1 Asia DNA & RNA Oligonucleotides Market Size by Type (2018-2024)
9.2.2 Asia DNA & RNA Oligonucleotides Market Size by Type (2024-2034)
9.2.3 Asia DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
9.3 Asia DNA & RNA Oligonucleotides Market Size by Application
9.3.1 Asia DNA & RNA Oligonucleotides Market Size by Application (2018-2024)
9.3.2 Asia DNA & RNA Oligonucleotides Market Size by Application (2024-2034)
9.3.3 Asia DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
9.4 Asia DNA & RNA Oligonucleotides Market Size by Region
9.4.1 Asia DNA & RNA Oligonucleotides Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia DNA & RNA Oligonucleotides Market Size by Region (2018-2024)
9.4.3 Asia DNA & RNA Oligonucleotides Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Type
10.2.1 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Application
10.3.1 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Country
10.4.1 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.1.5 Eurofins Scientific Recent Developments
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera DNA & RNA Oligonucleotides Introduction
11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.2.5 Natera Recent Developments
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI DNA & RNA Oligonucleotides Introduction
11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.3.5 BGI Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.4.5 Illumina Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche DNA & RNA Oligonucleotides Introduction
11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.6.5 LabCorp Recent Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.7.5 Berry Genomics Recent Developments
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Details
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.8.5 Brooks Life Sciences Recent Developments
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.9.5 Macrogen Recent Developments
11.10 Genotypic Technology
11.10.1 Genotypic Technology Company Details
11.10.2 Genotypic Technology Business Overview
11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.10.5 Genotypic Technology Recent Developments
11.11 Dna Link
11.11.1 Dna Link Company Details
11.11.2 Dna Link Business Overview
11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2018-2024)
11.11.5 Dna Link Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of DNA Oligonucleotides
Table 3. Key Players of RNA Oligonucleotides
Table 4. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global DNA & RNA Oligonucleotides Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global DNA & RNA Oligonucleotides Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global DNA & RNA Oligonucleotides Market Share by Region (2018-2024)
Table 8. Global DNA & RNA Oligonucleotides Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global DNA & RNA Oligonucleotides Market Share by Region (2024-2034)
Table 10. DNA & RNA Oligonucleotides Market Trends
Table 11. DNA & RNA Oligonucleotides Market Drivers
Table 12. DNA & RNA Oligonucleotides Market Challenges
Table 13. DNA & RNA Oligonucleotides Market Restraints
Table 14. Global DNA & RNA Oligonucleotides Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global DNA & RNA Oligonucleotides Revenue Share by Players (2018-2024)
Table 16. Global Top DNA & RNA Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2022)
Table 17. Global DNA & RNA Oligonucleotides Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by DNA & RNA Oligonucleotides Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of DNA & RNA Oligonucleotides, Headquarters and Area Served
Table 20. Global Key Players of DNA & RNA Oligonucleotides, Product and Application
Table 21. Global Key Players of DNA & RNA Oligonucleotides, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global DNA & RNA Oligonucleotides Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2018-2024)
Table 25. Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2024-2034)
Table 27. Global DNA & RNA Oligonucleotides Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global DNA & RNA Oligonucleotides Revenue Share by Application (2018-2024)
Table 29. Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global DNA & RNA Oligonucleotides Revenue Share by Application (2024-2034)
Table 31. North America DNA & RNA Oligonucleotides Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America DNA & RNA Oligonucleotides Market Size by Type (2024-2034) & (US$ Million)
Table 33. North America DNA & RNA Oligonucleotides Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America DNA & RNA Oligonucleotides Market Size by Application (2024-2034) & (US$ Million)
Table 35. North America DNA & RNA Oligonucleotides Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. North America DNA & RNA Oligonucleotides Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America DNA & RNA Oligonucleotides Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe DNA & RNA Oligonucleotides Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe DNA & RNA Oligonucleotides Market Size by Type (2024-2034) & (US$ Million)
Table 40. Europe DNA & RNA Oligonucleotides Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe DNA & RNA Oligonucleotides Market Size by Application (2024-2034) & (US$ Million)
Table 42. Europe DNA & RNA Oligonucleotides Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 43. Europe DNA & RNA Oligonucleotides Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe DNA & RNA Oligonucleotides Market Size by Country (2024-2034) & (US$ Million)
Table 45. China DNA & RNA Oligonucleotides Market Size by Type (2018-2024) & (US$ Million)
Table 46. China DNA & RNA Oligonucleotides Market Size by Type (2024-2034) & (US$ Million)
Table 47. China DNA & RNA Oligonucleotides Market Size by Application (2018-2024) & (US$ Million)
Table 48. China DNA & RNA Oligonucleotides Market Size by Application (2024-2034) & (US$ Million)
Table 49. Asia DNA & RNA Oligonucleotides Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia DNA & RNA Oligonucleotides Market Size by Type (2024-2034) & (US$ Million)
Table 51. Asia DNA & RNA Oligonucleotides Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia DNA & RNA Oligonucleotides Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia DNA & RNA Oligonucleotides Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 54. Asia DNA & RNA Oligonucleotides Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia DNA & RNA Oligonucleotides Market Size by Region (2024-2034) & (US$ Million)
Table 56. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Type (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Application (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 61. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size by Country (2024-2034) & (US$ Million)
Table 63. Eurofins Scientific Company Details
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific DNA & RNA Oligonucleotides Product
Table 66. Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 67. Eurofins Scientific Recent Developments
Table 68. Natera Company Details
Table 69. Natera Business Overview
Table 70. Natera DNA & RNA Oligonucleotides Product
Table 71. Natera Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 72. Natera Recent Developments
Table 73. BGI Company Details
Table 74. BGI Business Overview
Table 75. BGI DNA & RNA Oligonucleotides Product
Table 76. BGI Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 77. BGI Recent Developments
Table 78. Illumina Company Details
Table 79. Illumina Business Overview
Table 80. Illumina DNA & RNA Oligonucleotides Product
Table 81. Illumina Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 82. Illumina Recent Developments
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche DNA & RNA Oligonucleotides Product
Table 86. Roche Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 87. Roche Recent Developments
Table 88. LabCorp Company Details
Table 89. LabCorp Business Overview
Table 90. LabCorp DNA & RNA Oligonucleotides Product
Table 91. LabCorp Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 92. LabCorp Recent Developments
Table 93. Berry Genomics Company Details
Table 94. Berry Genomics Business Overview
Table 95. Berry Genomics DNA & RNA Oligonucleotides Product
Table 96. Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 97. Berry Genomics Recent Developments
Table 98. Brooks Life Sciences Company Details
Table 99. Brooks Life Sciences Business Overview
Table 100. Brooks Life Sciences DNA & RNA Oligonucleotides Product
Table 101. Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 102. Brooks Life Sciences Recent Developments
Table 103. Macrogen Company Details
Table 104. Macrogen Business Overview
Table 105. Macrogen DNA & RNA Oligonucleotides Product
Table 106. Macrogen Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 107. Macrogen Recent Developments
Table 108. Genotypic Technology Company Details
Table 109. Genotypic Technology Business Overview
Table 110. Genotypic Technology DNA & RNA Oligonucleotides Product
Table 111. Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 112. Genotypic Technology Recent Developments
Table 113. Dna Link Company Details
Table 114. Dna Link Business Overview
Table 115. Dna Link DNA & RNA Oligonucleotides Product
Table 116. Dna Link Revenue in DNA & RNA Oligonucleotides Business (2018-2024) & (US$ Million)
Table 117. Dna Link Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global DNA & RNA Oligonucleotides Market Share by Type: 2022 VS 2034
Figure 3. DNA Oligonucleotides Features
Figure 4. RNA Oligonucleotides Features
Figure 5. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 6. Global DNA & RNA Oligonucleotides Market Share by Application: 2022 VS 2034
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Biopharma Companies Case Studies
Figure 9. Academic & Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. DNA & RNA Oligonucleotides Report Years Considered
Figure 12. Global DNA & RNA Oligonucleotides Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global DNA & RNA Oligonucleotides Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global DNA & RNA Oligonucleotides Market Share by Region: 2022 VS 2034
Figure 15. Global DNA & RNA Oligonucleotides Market Share by Players in 2022
Figure 16. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by DNA & RNA Oligonucleotides Revenue in 2022
Figure 18. North America DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
Figure 20. North America DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
Figure 21. North America DNA & RNA Oligonucleotides Market Share by Country (2018-2034)
Figure 22. United States DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe DNA & RNA Oligonucleotides Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
Figure 26. Europe DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
Figure 27. Europe DNA & RNA Oligonucleotides Market Share by Country (2018-2034)
Figure 28. Germany DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China DNA & RNA Oligonucleotides Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
Figure 36. China DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
Figure 37. Asia DNA & RNA Oligonucleotides Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
Figure 39. Asia DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
Figure 40. Asia DNA & RNA Oligonucleotides Market Share by Region (2018-2034)
Figure 41. Japan DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America DNA & RNA Oligonucleotides Market Share by Country (2018-2034)
Figure 51. Brazil DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Eurofins Scientific Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 58. Natera Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 59. BGI Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 60. Illumina Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 61. Roche Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 62. LabCorp Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 63. Berry Genomics Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 64. Brooks Life Sciences Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 65. Macrogen Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 66. Genotypic Technology Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 67. Dna Link Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed